{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:04:50Z","timestamp":1777633490963,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Aldosterone plays important parts in development of cardio-metabolic diseases as end product of renin-angiotensin-aldosterone system. However, factors elevating circulating aldosterone are not clear, and lifestyle-related factors are suggested to be involved, whereas less studied. Therefore, we aimed to explore the association of lifestyle factors with plasma aldosterone concentration (PAC) in community population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this cross-sectional study, we recruited participants using multistage random sampling from Emin China in 2019, and collected data and fasting blood samples. The considered lifestyle factors included obesity parameters (neck circumference, abdominal circumference), alcohol consumption, blood pressure (BP), physical activity, sleep duration, sleep quality, mental state (depression and anxiety), fasting blood glucose (FBG), and lipid profiles (total cholesterol and triglyceride). PAC was measured using radioimmunoassay. We performed sex-stratified linear and logistic regressions to explore associated factors of PAC. Component analysis was further performed to identify the main factors affecting PAC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-seven thousand four hundred thirty-six\u00a0participants with 47.1% men were included. Obesity parameters (neck circumference, abdominal circumference), glucose metabolism (FBG), psychological status (anxiety status in men and women, depression status in men), BP, liver function (in men), lipid metabolism (TC and TG in men), sleep parameters (sleep quality in women), and renal function (in women) are the main factors associated with elevated PAC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>lower physical activity, alcohol consumption, higher BP, fat accumulation, dyslipidemia, higher fasting blood glucose, and presence of depression and anxiety were the main factors associated with eleveated PAC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-024-18796-0","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T03:38:30Z","timestamp":1716349110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Associated lifestyle factors of elevated plasma aldosterone concentration in community population, gender-stratified analysis of a cross-sectional survey"],"prefix":"10.1186","volume":"24","author":[{"given":"Adalaiti","family":"Maitituersun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mulalibieke","family":"Heizhati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shasha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiayire","family":"Aierken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaomiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,22]]},"reference":[{"key":"18796_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/joe.1.06017","volume":"186","author":"JM Connell","year":"2005","unstructured":"Connell JM, Davies E. The new biology of aldosterone. J Endocrinol. 2005;186:1\u201320. https:\/\/doi.org\/10.1677\/joe.1.06017.","journal-title":"J Endocrinol"},{"issue":"6","key":"18796_CR2","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/biom13061004","volume":"13","author":"M Crompton","year":"2023","unstructured":"Crompton M, Skinner LJ, Satchell SC, Butler MJ. Aldosterone: essential for life but damaging to the vascular endothelium. Biomolecules. 2023;13(6):1004. https:\/\/doi.org\/10.3390\/biom13061004","journal-title":"Biomolecules"},{"key":"18796_CR3","doi-asserted-by":"publisher","first-page":"100466","DOI":"10.1016\/j.ajpc.2023.100466","volume":"13","author":"V Kesireddy","year":"2023","unstructured":"Kesireddy V, Kluwe B, Pohlman N, et al. The role of aldosterone and ideal cardiovascular health in incident diabetes: the Jackson Heart Study. Am J Prev Cardiol. 2023;13:100466. https:\/\/doi.org\/10.1016\/j.ajpc.2023.100466.","journal-title":"Am J Prev Cardiol"},{"key":"18796_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/HJH.0000000000003049","volume":"40","author":"M Lin","year":"2022","unstructured":"Lin M, Mulalibieke H, Gan L, et al. Higher aldosterone is associated with increased renal impairment risk in patients with hypertension and abnormal glucose metabolism: a longitudinal study. J Hypertens. 2022;40:561\u20139. https:\/\/doi.org\/10.1097\/HJH.0000000000003049.","journal-title":"J Hypertens"},{"key":"18796_CR5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1161\/HYPERTENSIONAHA.121.18342","volume":"79","author":"Q Zhu","year":"2022","unstructured":"Zhu Q, Heizhati M, Lin M. Higher plasma aldosterone concentrations are associated with elevated risk of aortic dissection and aneurysm: a case-control study. Hypertension. 2022;79:736\u201346. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.18342.","journal-title":"Hypertension"},{"key":"18796_CR6","doi-asserted-by":"publisher","first-page":"1017177","DOI":"10.3389\/fendo.2022.1017177","volume":"13","author":"L Gan","year":"2022","unstructured":"Gan L, Li N, Heizhati M, et al. Higher plasma aldosterone is associated with increased risk of cardiovascular events in hypertensive patients with suspected OSA: UROSAH data. Front Endocrinol (Lausanne). 2022;13:1017177. https:\/\/doi.org\/10.3389\/fendo.2022.1017177.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"18796_CR7","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/eurheartj\/ehq019","volume":"31","author":"A Tomaschitz","year":"2010","unstructured":"Tomaschitz A, Pilz S, Ritz E, Meinitzer A, Boehm BO, Marz W. Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen risk and cardiovascular health (LURIC) study. Eur Heart J. 2010;31(10):1237\u201347. https:\/\/doi.org\/10.1093\/eurheartj\/ehq019.","journal-title":"Eur Heart J"},{"issue":"9","key":"18796_CR8","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jchf.2017.05.012","volume":"5","author":"JJ Joseph","year":"2017","unstructured":"Joseph JJ, Echouffo-Tcheugui JB, Kalyani RR, Yeh HC, Bertoni AG, Effoe VS, et al. Aldosterone, renin, cardiovascular events, and all-cause mortality among African Americans: the Jackson heart study. JACC Heart Fail. 2017;5(9):642\u201351. https:\/\/doi.org\/10.1016\/j.jchf.2017.05.012.","journal-title":"JACC Heart Fail"},{"key":"18796_CR9","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1210\/endo.133.5.8404675","volume":"133","author":"GK Adler","year":"1993","unstructured":"Adler GK, Chen R, Menachery AI, et al. Sodium restriction increases aldosterone biosynthesis by increasing late pathway, but not early pathway, messenger ribonucleic acid levels and enzyme activity in normotensive rats. Endocrinology. 1993;133:2235\u201340. https:\/\/doi.org\/10.1210\/endo.133.5.8404675.","journal-title":"Endocrinology"},{"key":"18796_CR10","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1210\/mend.9.8.7476975","volume":"9","author":"RG Allen","year":"1995","unstructured":"Allen RG, Carey C, Parker JD, et al. Targeted ablation of pituitary pre-proopiomelanocortin cells by herpes simplex virus-1 thymidine kinase differentially regulates mRNAs encoding the adrenocorticotropin receptor and aldosterone synthase in the mouse adrenal gland. Mol Endocrinol. 1995;9:1005\u201316. https:\/\/doi.org\/10.1210\/mend.9.8.7476975.","journal-title":"Mol Endocrinol"},{"issue":"5","key":"18796_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/nu11050955","volume":"11","author":"V Kesireddy","year":"2019","unstructured":"Kesireddy V, Tan Y, Kline D, et al. The association of Life\u2019s simple 7 with Aldosterone among African Americans in the Jackson Heart Study. Nutrients. 2019;11(5): 955. https:\/\/doi.org\/10.3390\/nu11050955.","journal-title":"Nutrients"},{"key":"18796_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-3-15","volume":"3","author":"H Murck","year":"2003","unstructured":"Murck H, Held K, Ziegenbein M, et al. The renin-angiotensin-aldosterone system in patients with depression compared to controls - a sleep endocrine study. BMC Psychiatry. 2003;3: 15. https:\/\/doi.org\/10.1186\/1471-244X-3-15.","journal-title":"BMC Psychiatry"},{"key":"18796_CR13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.arcmed.2005.03.046","volume":"36","author":"E Emanuele","year":"2005","unstructured":"Emanuele E, Geroldi D, Minoretti P, et al. Increased plasma aldosterone in patients with clinical depression. Arch Med Res. 2005;36:544\u20138. https:\/\/doi.org\/10.1016\/j.arcmed.2005.03.046.","journal-title":"Arch Med Res"},{"key":"18796_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/jhh.2014.33","volume":"29","author":"SR Collier","year":"2015","unstructured":"Collier SR, Sandberg K, Moody AM, et al. Reduction of plasma aldosterone and arterial stiffness in obese pre- and stage1 hypertensive subjects after aerobic exercise. J Hum Hypertens. 2015;29:53\u20137. https:\/\/doi.org\/10.1038\/jhh.2014.33.","journal-title":"J Hum Hypertens"},{"key":"18796_CR15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1113\/expphysiol.2007.037408","volume":"92","author":"JM Jones","year":"2007","unstructured":"Jones JM, Dowling TC, Park JJ, et al. Differential aerobic exercise-induced changes in plasma aldosterone between African Americans and Caucasians. Exp Physiol. 2007;92:871\u20139. https:\/\/doi.org\/10.1113\/expphysiol.2007.037408.","journal-title":"Exp Physiol"},{"key":"18796_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/hr.2015.100","volume":"39","author":"K Goessler","year":"2016","unstructured":"Goessler K, Polito M, Cornelissen VA. Effect of exercise training on the renin-angiotensin-aldosterone system in healthy individuals: a systematic review and meta-analysis. Hypertens Res. 2016;39:119\u201326. https:\/\/doi.org\/10.1038\/hr.2015.100.","journal-title":"Hypertens Res"},{"issue":"2","key":"18796_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.114.04488","volume":"65","author":"J Bauersachs","year":"2015","unstructured":"Bauersachs J, Jaisser F, Toto R. Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases. Hypertension. 2015;65(2):257\u201363. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.04488.","journal-title":"Hypertension"},{"key":"18796_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107701","volume":"219","author":"C Cosimato","year":"2021","unstructured":"Cosimato C, Agoritsas T, Mavrakanas TA. Mineralocorticoid receptor antagonists in patients with chronic kidney disease. Pharmacol Ther. 2021;219: 107701. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107701.","journal-title":"Pharmacol Ther"},{"key":"18796_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000665","author":"JM Feldman","year":"2024","unstructured":"Feldman JM, Frishman WH, Aronow WS. Emerging therapies for treatment-resistant hypertension: a review of lorundrostat and related selective aldosterone synthase inhibitors. Cardiol Rev. 2024. https:\/\/doi.org\/10.1097\/CRD.0000000000000665.","journal-title":"Cardiol Rev"},{"key":"18796_CR20","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1001\/jama.2023.16029","volume":"330","author":"L Laffin","year":"2023","unstructured":"Laffin L, Rodman D, Luther J, et al. Aldosterone synthase inhibition with lorundostat for uncontrolled hypertension the target-HTN randomized clinical trial. JAMA. 2023;330:1140\u201350. https:\/\/doi.org\/10.1001\/jama.2023.16029.","journal-title":"JAMA"},{"key":"18796_CR21","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.2147\/NSS.S329024","volume":"13","author":"Z Yang","year":"2021","unstructured":"Yang Z, Heizhati M, Wang L, et al. Subjective poor sleep quality is associated with higher blood pressure and prevalent hypertension in general population independent of sleep disordered breathing. Nat Sci Sleep. 2021;13:1759\u201370. https:\/\/doi.org\/10.2147\/NSS.S329024.","journal-title":"Nat Sci Sleep"},{"key":"18796_CR22","doi-asserted-by":"publisher","first-page":"1016804","DOI":"10.3389\/fendo.2022.1016804","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang H, Heizhati M, Li N, et al. Association of objective and subjective parameters of obstructive sleep apnea with plasma aldosterone concentration in 2,066 hypertensive and 25,368 general population. Front Endocrinol (Lausanne). 2022;13:1016804. https:\/\/doi.org\/10.3389\/fendo.2022.1016804.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"18796_CR23","volume-title":"Global recommendations on physical activity for health","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Global recommendations on physical activity for health. 2010. Available from: http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599979_eng.pdf . Accessed 6 Nov 2018 ."},{"key":"18796_CR24","volume-title":"Global recommendations on physical activity for health [EB\/OL]","author":"WHO","year":"2010","unstructured":"WHO. Global recommendations on physical activity for health [EB\/OL]. 2010. http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599979_eng."},{"key":"18796_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193\u2013213. https:\/\/doi.org\/10.1016\/0165-1781(89)90047-4.","journal-title":"Psychiatry Res"},{"key":"18796_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.smrv.2015.01.009","volume":"25","author":"T Mollayeva","year":"2016","unstructured":"Mollayeva T, Thurairajah P, Burton K, Mollayeva S, Shapiro CM, Colantonio A. The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: a systematic review and meta-analysis. Sleep Med Rev. 2016;25:52\u201373. https:\/\/doi.org\/10.1016\/j.smrv.2015.01.009.","journal-title":"Sleep Med Rev"},{"key":"18796_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1590\/S1679-45082012000300013","volume":"10","author":"RA Tibana","year":"2012","unstructured":"Tibana RA, Teixeira TG, Farias DL, et al. Relation of neck circumference and relative muscle strength and cardiovascular risk factors in sedentary women. Einstein (Sao Paulo). 2012;10:329\u201334.","journal-title":"Einstein (Sao Paulo)"},{"key":"18796_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/cen.14199","volume":"93","author":"P Solanki","year":"2020","unstructured":"Solanki P, Gwini SM, Doery JC, et al. Age- and sex-specific reference ranges are needed for the aldosterone\/renin ratio. Clin Endocrinol (Oxf). 2020;93:221\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"18796_CR29","doi-asserted-by":"publisher","unstructured":"Hespel P, Lijnen P, Van Hoof R, et al. Effects of physical endurance training on the plasma renin-angiotensin-aldosterone system in normal man. J Endocrinol. 116;443\u2013449. https:\/\/doi.org\/10.1677\/joe.0.1160443.","DOI":"10.1677\/joe.0.1160443"},{"key":"18796_CR30","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/s0735-1097(99)00339-3","volume":"34","author":"RW Braith","year":"1999","unstructured":"Braith RW, Welsch MA, Feigenbaum MS, Kluess HA, Pepine CJ. Neuroendocrine activation in heart failure is modified by endurance exercise training. J Am Coll Cardiol. 1999;34:1170\u20135. https:\/\/doi.org\/10.1016\/s0735-1097(99)00339-3.","journal-title":"J Am Coll Cardiol"},{"key":"18796_CR31","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/s41440-023-01203-3","volume":"46","author":"WC Huang","year":"2023","unstructured":"Huang WC, Chen YY, Yang SY, et al. Fat mass as an important predictor of persistent hypertension in patients with primary aldosteronism after adrenalectomy. Hypertens Res. 2023;46:1375\u201384. https:\/\/doi.org\/10.1038\/s41440-023-01203-3.","journal-title":"Hypertens Res"},{"key":"18796_CR32","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","volume":"59","author":"M Briones Ana","year":"2012","unstructured":"Briones Ana M, Nguyen DC, Aurelie, Callera Glaucia E, et al. Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension. 2012;59:1069\u201378. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.190223.","journal-title":"Hypertension"},{"key":"18796_CR33","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12933-020-01095-4","volume":"19","author":"H Wan","year":"2020","unstructured":"Wan H, Wang Y, Xiang Q, et al. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020;19:118. https:\/\/doi.org\/10.1186\/s12933-020-01095-4.","journal-title":"Cardiovasc Diabetol"},{"key":"18796_CR34","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/jcsm.12933","volume":"13","author":"Z Chen","year":"2022","unstructured":"Chen Z, Ho M, Chau PH. Handgrip strength asymmetry is associated with the risk of neurodegenerative disorders among Chinese older adults. J Cachexia Sarcopenia Muscle. 2022;13:1013\u201323. https:\/\/doi.org\/10.1002\/jcsm.12933.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"18796_CR35","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/mp.2017.97","volume":"23","author":"EG Aoun","year":"2018","unstructured":"Aoun EG, Jimenez VA, Vendruscolo LF, et al. A relationship between the aldosterone-mineralocorticoid receptor pathway and alcohol drinking: preliminary translational findings across rats, monkeys and humans. Mol Psychiatry. 2018;23:1466\u201373. https:\/\/doi.org\/10.1038\/mp.2017.97.","journal-title":"Mol Psychiatry"},{"key":"18796_CR36","doi-asserted-by":"publisher","first-page":"105685","DOI":"10.1016\/j.psyneuen.2022.105685","volume":"139","author":"A Gideon","year":"2022","unstructured":"Gideon A, Sauter C, Deuber J, et al. Aldosterone secretion during the day: salivary aldosterone awakening response and daytime levels. Psychoneuroendocrinology. 2022;139:105685. https:\/\/doi.org\/10.1016\/j.psyneuen.2022.105685.","journal-title":"Psychoneuroendocrinology"},{"key":"18796_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jpsychires.2020.07.006","volume":"130","author":"H Murck","year":"2020","unstructured":"Murck H, Schlageter L, Schneider A, et al. The potential pathophysiological role of aldosterone and the mineralocorticoid receptor in anxiety and depression - lessons from primary aldosteronism. J Psychiatr Res. 2020;130:82\u20138. https:\/\/doi.org\/10.1016\/j.jpsychires.2020.07.006.","journal-title":"J Psychiatr Res"},{"key":"18796_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.yhbeh.2008.02.004","volume":"54","author":"N Hlavacova","year":"2008","unstructured":"Hlavacova N, Jezova D. Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior. Horm Behav. 2008;54:90\u20137. https:\/\/doi.org\/10.1016\/j.yhbeh.2008.02.004.","journal-title":"Horm Behav"},{"key":"18796_CR39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41440-018-0131-4","volume":"42","author":"M Heizhati","year":"2019","unstructured":"Heizhati M, Zhang Y, Shao L, et al. Decreased serum potassium may disturb sleep homeostasis in essential hypertensives. Hypertens Res. 2019;42:174\u201381. https:\/\/doi.org\/10.1038\/s41440-018-0131-4.","journal-title":"Hypertens Res"}],"updated-by":[{"DOI":"10.1186\/s12889-024-19323-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000}}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-18796-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-024-18796-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-18796-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T10:04:08Z","timestamp":1728036248000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-024-18796-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,22]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["18796"],"URL":"https:\/\/doi.org\/10.1186\/s12889-024-18796-0","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12889-024-19323-x","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,22]]},"assertion":[{"value":"4 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12889-024-19323-x","URL":"https:\/\/doi.org\/10.1186\/s12889-024-19323-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving research study participants were approved by The Independent Ethics Committee of People\u2019s Hospital of Xinjiang Uygur Autonomous Region. Signed informed consent was obtained from all of the eligible participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1370"}}